Cotellic (cobimetinib)

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) May 2016 WARNINGS AND PRECAUTIONS Hepatic Impairment (update) Adjustment in the starting dose of COTELLIC is not required in...
Source: Drugs.com - Labeling Changes - Category: Drugs & Pharmacology Source Type: alerts